Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what guidance is provided to Personal Independence Payment assessors on considering the effects of active medical treatment on claimants’ functional ability.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
Personal Independence Payment (PIP) assessments focus on the functional impact of a claimant’s health condition, rather than diagnosis or treatment alone. At assessment, Health Professionals (HPs) gather information on any past, current and ongoing medical treatment related to conditions that impact function, including medication, therapy, monitoring, side effects and effectiveness. Where necessary to properly inform their advice, HPs should and routinely do seek additional evidence from treating health professionals or other appropriate sources.
Medical treatment is covered throughout training and guidance, and HPs routinely consider the effects of ongoing medical treatment on functional ability when advising on appropriate descriptors. This includes both positive effects, where treatment enables activities to be completed more reliably, and negative effects, such as side effects or symptom fluctuation. These factors are particularly important when applying the reliability criteria, including whether an activity can be carried out safely, to an acceptable standard, repeatedly, and within a reasonable time. The impact of treatment is also assessed directly within activity 3, which relates to managing therapy or monitoring a health condition.
Where symptoms fluctuate, including because of treatment variability, HPs assess functional impact over a 12-month period to reflect good and bad days and determine how descriptors apply on the majority of days. HPs also consider what medical treatment is being undertaken when advising on a recommended review date, aligning this with the point at which an individual’s functional needs could reasonably be expected to change, for example following recovery or changes to treatment. Claimants are also expected to notify the Department directly of any changes in their condition or circumstances, so that their award can be reviewed where appropriate.
Asked by: Simon Opher (Labour - Stroud)
Question to the Department for Digital, Culture, Media & Sport:
To ask the Secretary of State for Culture, Media and Sport, what steps she is taking to support orchestras.
Answered by Ian Murray - Minister of State (Department for Science, Innovation and Technology)
The Government is proud to champion our world-class orchestras and musicians, and help them to thrive. Through Arts Council England’s (ACE) 2023–26 National Portfolio Investment Programme, more money is going to more orchestral organisations in more parts of the country than ever before.The National Portfolio is supporting 139 organisations classed as ‘music’ by investing around £65 million of public funding per annum. ACE investment in classical music remains high, in particular in orchestral music organisations, with 23 such organisations being funded to the tune of around £21 million per annum. We are also supporting orchestras through the tax system, confirming from April 2025 that Orchestra Tax Relief on production costs would be set at the generous rate of 45 per cent.
Over the course of this Parliament, we will also make a £1.5 billion capital investment into fulfilling our Arts Everywhere ambitions. This funding package includes £425 million for the Creative Foundations Fund, revitalising and renewing performing arts buildings across England, including resident venues and key stops on orchestral tours. We will also, for the first time, provide £80 million of capital funding to the National Portfolio Investment Programme over the next four years. This means that Arts Council England will be able to give around 1,000 cultural organisations a 5% uplift in their regular funding; the single biggest uplift to an existing Portfolio in decades.
Asked by: Mark Pritchard (Conservative - The Wrekin)
Question to the Department for Digital, Culture, Media & Sport:
To ask the Secretary of State for Culture, Media and Sport, if she will review the decision taken earlier this year not to award funding to the Wellington Orbit from the Creative Foundations Fund.
Answered by Ian Murray - Minister of State (Department for Science, Innovation and Technology)
The Creative Foundation Fund, announced in 2025 as part of the Arts Everywhere Fund, is being delivered by Arts Council England. The Arts Council makes decisions about which organisations and projects to fund independently of government and Ministers, which means there is no question of any political involvement in arts funding decisions. It would, therefore, be inappropriate for Ministers to ask Arts Council England to revisit their decision on the application made by Wellington Orbit. Demand for this fund in its first round was extremely high, with a large number of applicants demonstrating the ability to meet the programme aims. As a result, the Arts Council had to make very difficult decisions about which applicants to invite to the full application stage. This was to ensure that applicants did not spend time and resources completing an application with very limited chance of success in that round.
The Secretary of State for Culture, Media and Sport has recently announced a new round of the Arts Everywhere Fund, including up to £340 million of new funding for the Creative Foundations Fund, which will be invested from 2026/27 up to and including 2029/30. Wellington Orbit may wish to submit an application. Arts Council England will announce further details regarding the application process and eligibility criteria in due course.
Asked by: Ian Lavery (Labour - Blyth and Ashington)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if he will make and assessment of the potential merits of reviewing the Control of Substances Hazardous to Health Regulations 2002 to ensure that hazardous medicinal products with reprotoxic effects are controlled to the same standard as carcinogens and mutagens.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
I refer the hon. Member to the answer I gave on 30 October 2025 to Question UIN 84440.
Asked by: Adam Dance (Liberal Democrat - Yeovil)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the level of funding in hospice care in Yeovil constituency.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Palliative care services are included in the list of services an integrated care board (ICB) must commission, including the Somerset ICB, which covers the Yeovil constituency. To support ICBs in this duty, NHS England has published statutory guidance and service specifications. The statutory guidance states that ICBs must work to ensure that there is sufficient provision of care services to meet the needs of their local populations, which can include hospice services available within the ICB catchment.
We are supporting the hospice sector with an initial £100 million investment and a recent additional £25 million capital funding boost for eligible adult and children’s hospices in England to ensure they have the best physical environment for care. The full £125 million has now been allocated to 158 eligible hospices by Hospice UK, and I can confirm that St Margaret’s Hospice in the Yeovil constituency is receiving £986,184 from this capital funding.
The capital funding is helping hospices to provide the best end of life care to patients and their families in a supportive and dignified physical environment. Funding helps to support hospices and deliver much needed improvements including refurbishments, overhauling IT systems, and improving facilities for patients and visitors.
Additionally, children and young people’s hospices will receive £26 million in revenue funding this year. We have also confirmed the continuation of this funding stream, approximately totalling £80 million of revenue funding over the next three years, which will provide stability for the sector over that period.
More widely, the Government is developing a Palliative Care and End-of-Life Care Modern Service Framework. Contracting and commissioning arrangements will be considered as part of this work.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will take steps to increase the number of places for domestic students on medical courses in universities.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
In England, the Office for Students (OfS) sets the maximum fundable limit for medical school places on an annual basis. OfS will publish its intake target for the 2026/27 academic year in due course.
For the 2025/26 academic year, OfS has published its intake target at 8,126 for medical school places, with further information available at the following link:
On 28 January, the Medical Training (Prioritisation) Bill was introduced in the House of Lords. This bill implements the Government’s commitment in the 10-Year Health Plan to prioritise UK medical graduates for foundation training places, and to prioritise UK medical graduates and other doctors with significant NHS experience for specialty places.
Asked by: Maureen Burke (Labour - Glasgow North East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has had recent discussions with Marie Curie on funding for the hospice sector.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Last year, I met key palliative care and end-of-life care stakeholders, including Marie Curie, in a roundtable format with a focus on long-term sector sustainability within the context of our 10-Year Health Plan.
The Government is developing a Palliative Care and End-of-Life Care Modern Service Framework (MSF) for England, and we will consider contracting and commissioning arrangements as part of this work. We recognise that there is currently a mix of contracting models in the hospice sector. By supporting integrated care boards to commission more strategically, we can move away from grant and block contract models. In the long term, this will aid sustainability and help hospices’ ability to plan ahead.
Officials are working closely with Marie Curie and a number of other stakeholders from the hospice sector in the development of the MSF.
Asked by: Mike Wood (Conservative - Kingswinford and South Staffordshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the answer of 11 December 2025 to Question 94707 on Department of Health and Social Care and NHS England: Flags, if he will list each flag, for flying from buildings that his Department hold.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department holds a range of flags including the National Health Service flag and the commonwealth flag that are flown when instructed to by the Department for Culture, Media and Sport. The Union flag is flown the majority of the year.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, how fluctuating symptoms are taken into account within Personal Independence Payment assessments.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
Personal Independence Payment (PIP) assessments focus on the functional impact of a claimant’s health condition, rather than diagnosis or treatment alone. At assessment, Health Professionals (HPs) gather information on any past, current and ongoing medical treatment related to conditions that impact function, including medication, therapy, monitoring, side effects and effectiveness. Where necessary to properly inform their advice, HPs should and routinely do seek additional evidence from treating health professionals or other appropriate sources.
Medical treatment is covered throughout training and guidance, and HPs routinely consider the effects of ongoing medical treatment on functional ability when advising on appropriate descriptors. This includes both positive effects, where treatment enables activities to be completed more reliably, and negative effects, such as side effects or symptom fluctuation. These factors are particularly important when applying the reliability criteria, including whether an activity can be carried out safely, to an acceptable standard, repeatedly, and within a reasonable time. The impact of treatment is also assessed directly within activity 3, which relates to managing therapy or monitoring a health condition.
Where symptoms fluctuate, including because of treatment variability, HPs assess functional impact over a 12-month period to reflect good and bad days and determine how descriptors apply on the majority of days. HPs also consider what medical treatment is being undertaken when advising on a recommended review date, aligning this with the point at which an individual’s functional needs could reasonably be expected to change, for example following recovery or changes to treatment. Claimants are also expected to notify the Department directly of any changes in their condition or circumstances, so that their award can be reviewed where appropriate.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, how ongoing medical treatment is taken into account within Personal Independence Payment assessments.
Answered by Stephen Timms - Minister of State (Department for Work and Pensions)
Personal Independence Payment (PIP) assessments focus on the functional impact of a claimant’s health condition, rather than diagnosis or treatment alone. At assessment, Health Professionals (HPs) gather information on any past, current and ongoing medical treatment related to conditions that impact function, including medication, therapy, monitoring, side effects and effectiveness. Where necessary to properly inform their advice, HPs should and routinely do seek additional evidence from treating health professionals or other appropriate sources.
Medical treatment is covered throughout training and guidance, and HPs routinely consider the effects of ongoing medical treatment on functional ability when advising on appropriate descriptors. This includes both positive effects, where treatment enables activities to be completed more reliably, and negative effects, such as side effects or symptom fluctuation. These factors are particularly important when applying the reliability criteria, including whether an activity can be carried out safely, to an acceptable standard, repeatedly, and within a reasonable time. The impact of treatment is also assessed directly within activity 3, which relates to managing therapy or monitoring a health condition.
Where symptoms fluctuate, including because of treatment variability, HPs assess functional impact over a 12-month period to reflect good and bad days and determine how descriptors apply on the majority of days. HPs also consider what medical treatment is being undertaken when advising on a recommended review date, aligning this with the point at which an individual’s functional needs could reasonably be expected to change, for example following recovery or changes to treatment. Claimants are also expected to notify the Department directly of any changes in their condition or circumstances, so that their award can be reviewed where appropriate.